Pharmaceuticals News and Research

RSS

New method for bone tissue engineering wins award

A new and better method for accelerating bone formation in cases of orthopedic injuries and conditions, such as osteoporosis, fractures and disc disorders, has been developed by Nadav Kimelman at the Hebrew University of Jerusalem's Faculty of Dental Medicine.

23 Jun 2008

Pharmaceutical companies lobbying States to restrict use of lower-cost generic alternatives

Pharmaceutical companies, which "have been waging war against inexpensive generic drugs for years at the national level," are now "taking their fights to the states, promoting proposals that would" bar pharmacists from automatically replacing prescriptions for brand-name drugs with generics, the Baltimore Sun reports.

17 Jun 2008

Australian-made vaccine will protect against bird flu

An Australian-made vaccine which now has approval from the Therapeutic Goods Administration (TGA) could be used in the event of a bird flu pandemic.

17 Jun 2008

Largest ever Canadian study on osteoporosis informs health policy

Dr David Goltzman and his team from the Research Institute of the McGill University Health Centre (RI MUHC) and McGill University - along with colleagues from across Canada - have issued new recommendations to public health authorities about how to best cope with osteoporosis, a bone disease which leads to increased risk of fracture, particularly in the elderly.

16 Jun 2008

Peregrine Pharmaceuticals awarded two new U.S. patents for targeted anti-aminophospholipid agents

Peregrine Pharmaceuticals, Inc. today reported the issuance of two U.S. patents that significantly broaden the company's intellectual property leadership in the field of targeted anti-aminophospholipid agents.

16 Jun 2008

Concerns over placebo pill for kids

Responding to reports in the media that Obecalp, a placebo pill for children, is due to be made available on the UK market, the Royal Pharmaceutical Society of Great Britain's (RPSGB) Chief Scientist, Jayne Lawrence said:

16 Jun 2008

Mylan announces FDA approval for generic Effexor and tentative approval for generic antihypertensive Avalide

Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl) Tablets 25 mg (base), 37.5 mg (base), 50 mg (base), 75 mg (base) and 100 mg (base).

16 Jun 2008

VistaGen Therapeutics announces new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells

VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.

16 Jun 2008

Diabetic women get less intense treatment of heart disease than men

Women with type 2 diabetes and heart disease have poorer control of both diseases and receive less intensive medical treatment than do men, a large new study found. The results have been presented Sunday, June 15, at The Endocrine Society’s 90th Annual Meeting in San Francisco.

16 Jun 2008

High blood pressure treatment effective in reversing vascular damage

A hypertension medication called olmesartan medoxomil is effective in reversing the narrowing of the arteries that occurs in patients with high blood pressure, according to a new study.

16 Jun 2008

PolyTherics and Alligator Bioscience announce strategic collaboration for optimisation of next generation biopharmaceuticals

PolyTherics Ltd, a biopharmaceutical company specialised in the targeted application of polymers to biopharmaceuticals, and Alligator Bioscience AB ("Alligator"), a biotechnology company applying proprietary technology to the improvement of proteins, today announced the establishment of a new alliance.

16 Jun 2008

Collaborative effort by FDA and EMEA expected to yield additional safety data when assessing new drugs

In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) worked together to allow drug companies to submit the results of seven new tests that evaluate kidney damage during animal studies of new drugs. The tests measure the levels of seven key proteins or "biomarkers" found in urine that can provide additional information about drug-induced damage to kidney cells, also known as renal toxicity.

15 Jun 2008

Industry supports international melanoma research

Provectus Pharmaceuticals and the Australia and New Zealand Melanoma Trials Group (ANZMTG) have joined forces to advance cutting edge melanoma research at the University of Sydney.

15 Jun 2008

Scientist deciphers language bacterial cells use to 'talk' to each other - also discovers how to quell their conversation

Understanding the way bacterial cells "talk" to each other could lead to more effective methods for fighting the often persistent and serious infections caused by the biofilms they form, says a Texas A&M University professor of chemical engineering who not only has deciphered their language but also discovered how to quell their conversation.

11 Jun 2008

Vitamin D, "the heart tranquilizer"

Strong bones, a healthy immune system, protection against some types of cancer: Recent studies suggest there's yet another item for the expanding list of vitamin D benefits. Vitamin D, "the sunshine vitamin," keeps the heart, the body's long-distance runner, fit for life's demands.

11 Jun 2008

EntreMed receives new patent for 2-Methoxyestradiol analogs

EntreMed, Inc. has announced the issuance of U.S. Patent No. 7,371,741 covering analogs of 2- methoxyestradiol (2ME2).

11 Jun 2008

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Compugen Ltd. announced today the discovery of more than ten novel targets of antibody therapy for various types of solid and hematopoietic cancer.

11 Jun 2008

Without increased funding, California's dominance and public health are threatened, according to new report

The California Healthcare Institute (CHI) and PricewaterhouseCoopers (PwC) today released a report, "The National Institutes of Health: Fueling Healthcare Innovation in California," urging legislators to support increased funding for the National Institutes of Health (NIH) - the backbone of the biomedical industry in California, which employs more than 267,000 people in high wage jobs.

11 Jun 2008

New treatments for lower back pain tested

"This is one of the most frustrating complaints that patients have as they get older." Physicians are testing two drugs approved to treat other conditions to see whether they might also help patients who have severe pain in their lower back and in their legs.

11 Jun 2008

Mylan wins generic Prilosec patent litigation

Mylan Inc. has announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a May 2007 District Court ruling stating that Mylan's 10 mg and 20 mg Omeprazole delayed-release capsules do not infringe patents asserted against Mylan by AstraZeneca.

11 Jun 2008

Pharmaceuticals News and Research

New method for bone tissue engineering wins award

Pharmaceutical companies lobbying States to restrict use of lower-cost generic alternatives

Australian-made vaccine will protect against bird flu

Largest ever Canadian study on osteoporosis informs health policy

Peregrine Pharmaceuticals awarded two new U.S. patents for targeted anti-aminophospholipid agents

Concerns over placebo pill for kids

Mylan announces FDA approval for generic Effexor and tentative approval for generic antihypertensive Avalide

VistaGen Therapeutics announces new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells

Diabetic women get less intense treatment of heart disease than men

High blood pressure treatment effective in reversing vascular damage

PolyTherics and Alligator Bioscience announce strategic collaboration for optimisation of next generation biopharmaceuticals

Collaborative effort by FDA and EMEA expected to yield additional safety data when assessing new drugs

Industry supports international melanoma research

Scientist deciphers language bacterial cells use to 'talk' to each other - also discovers how to quell their conversation

Vitamin D, "the heart tranquilizer"

EntreMed receives new patent for 2-Methoxyestradiol analogs

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Without increased funding, California's dominance and public health are threatened, according to new report

New treatments for lower back pain tested

Mylan wins generic Prilosec patent litigation

Free eBook - From lab to market: Accelerate your bioprocessing journey eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring